Results 41 to 50 of about 47,491 (152)

Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature

Allergy, Asthma & Clinical Immunology, 2018
Background Oral vancomycin is a first-line treatment for severe Clostridium difficile colitis. Oral vancomycin is perceived to lack systemic absorption or systemic adverse effects; however, a few cases of hypersensitivity to oral vancomycin have been ...
Jeremy Barron, Adolfo Lattes, Esther-Lee Marcus   +2 more
doaj   +1 more source

Vancomycin and the Kidney

American Journal of Kidney Diseases, 1986
V ANCOMYCIN, a glycopeptide antibiotic, obtained as a fermentation product from Nocardia orienta lis (formerly Streptomyces orientalis), was first developed in the mid-1950s. 1.2 Some closely related biologic products are copurified with the predominant active compound designated vancomycin B. Initially, vancomycin had a unique role in the treatment of
G B, Appel, D B, Given, L R, Levine, G L, Cooper   +3 more
openaire   +2 more sources

Renal Protective Effect of Sulbutiamine, Thiamine, Riboflavin and their Combinations on Vancomycin-Induced Acute Renal Failure in Male Rats

Iraqi Journal of Pharmaceutical Sciences
Background: The main mechanisms thought to be involved in the pathophysiology of acute renal failure with vancomycin treatment are oxidative stress, inflammation and apoptosis.  In this study we evaluated the potential effects of sulbutiamine, thiamine,
Dayan K. Jabbar , Ghaith A. Jasim, Muthana I. Al-Ezzi   +2 more
doaj   +1 more source

Immunoglobulin E-mediated hypersensitivity reaction after intraperitoneal administration of vancomycin

Kidney Research and Clinical Practice, 2015
Intraperitoneal (IP) vancomycin is widely used to treat Gram-positive peritonitis associated with peritoneal dialysis. There have been two cases of red man syndrome (RMS), a vancomycin-specific nonimmunologic reaction, associated with IP vancomycin ...
Mun-Ju Hwang, Jun-Young Do, Eun-Woo Choi, Joon-Hyuk Seo, Yoon-Jung Nam, Kyung-Woo Yoon, Jong-Won Park, Kyu-Hyang Cho, Seok-Hui Kang, Hyun-Jung Jin   +9 more
doaj   +1 more source

Vancomycin tolerance in Gram-positive cocci

, 2011
Vancomycin, a glycopeptide antimicrobial agent, represents the last line of defence against a wide range of multi-resistant Gram-positive pathogens such as enterococci, staphylococci and streptococci.
Moscoso, Miriam, Domenech Lucas, Miriam, García, Ernesto   +2 more
core   +1 more source

Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro

Open Medicine, 2018
Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aureus (MRSA) infection for many years. However, the rise of MRSA infection rates and the extensive use of vancomycin have led to the emergence of reduced ...
Xu Jia, Pang Long, Ma Xiao Xue, Hu Jian, Tian Yuan, Yang Ya Li, Sun Dan Dan   +6 more
doaj   +1 more source

Environmental contamination by vancomycin resistant enterococci (VRE) in Swedish broiler production

Acta Veterinaria Scandinavica, 2009
Background Vancomycin resistant enterococci are a frequent cause of nosocomial infections and their presence among farm animals is unwanted. Using media supplemented with vancomycin an increase in the proportion of samples from Swedish broilers positive ...
Nilsson Oskar, Greko Christina, Bengtsson Björn   +2 more
doaj   +1 more source

Vancomycin Pharmacokinetic Parameters in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

International Journal of Hematology-Oncology and Stem Cell Research, 2013
Background: Vancomycin is used abundantly in patients undergoing HSCT, especially during neutropenic fever. Despite its widespread use little is known about vancomycin pharmacokinetics in HSCT patients.
Maryam Taghizadeh Ghehi, Saeed Rezaee, Alireza Hayatshahi, Molouk Hadjibabaie, Kheirollah Gholami, Mohammadreza Javadi, Seyed Hamid Khoee, Mania Radfar, Mohsen Esfandbod, Ardeshir Ghavamzadeh   +9 more
doaj  

A rare case of infant eosinophilia induced by oral vancomycin: a case report and literature review

Journal of International Medical Research, 2023
Oral vancomycin is mainly used to treat and prevent active Clostridium difficile infection. Because it is widely believed that there is a very low absorption rate via the gastrointestinal tract, reports of adverse reactions following oral vancomycin ...
Yali Wu, Wei Yin, Shan Guo, Fang Wang
doaj   +1 more source

Study of antibiotic efficacy of topical vancomycin powder in treatment of infected mandibular fractures and soft tissue surgical site infections

Journal of Family Medicine and Primary Care, 2019
Aims and Objective: To study the antibiotic efficacy of topical vancomycin in infected mandibular fracture treatment and its effect in preventing surgical site infections.
Geeta Singh, Deepak Passi, Deepti Daga, Abhigyan Manas, U Vignesh, Sujay Milind Bhave   +5 more
doaj   +1 more source